APT Medical

SHA-688617
Shanghai Stock Exchange
Healthcare Medical Devices
Global Rank
#3027
Country Rank
#431
Market Cap
5.39 B
Price
38.05
Change (%)
0.71%
Volume
502,860

APT Medical's latest marketcap:

5.39 B

As of 06/20/2025, APT Medical's market capitalization has reached $5.39 B. According to our data, APT Medical is the 3027th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 5.39 B
Revenue (ttm) 302.73 M
Net Income (ttm) 99.69 M
Shares Out 141.01 M
EPS (ttm) 0.71
Forward PE 43.11
Ex-Dividend Date 06/19/2025
Earnings Date 08/22/2025
Market Cap Chart
Data Updated: 06/20/2025

APT Medical's yearly market capitalization.

APT Medical has seen its market value drop from ¥18.67 B to ¥5.39 B since 2021, representing a total decrease of 71.14% and an annual compound decline rate (CAGR) of 30.09%.
Date Market Cap Change (%) Global Rank
06/20/2025 ¥5.39 B 8.22% 3027
12/31/2024 ¥36.09 B 39.61% 3011
12/29/2023 ¥25.85 B 26.35% 3677
12/30/2022 ¥20.46 B 9.62% 4048
12/31/2021 ¥18.67 B 4798

Company Profile

About APT Medical Inc.

APT Medical Inc. is a leading company specializing in the research, development, manufacturing, and supply of advanced medical devices, primarily in the fields of electrophysiology and vascular intervention. Headquartered in Shenzhen, China, the company has been serving the healthcare industry since its founding in 2002.

Product Offerings

Electrophysiological Products:

  • Mapping catheters
  • Ablation catheters
  • Transseptal needles and sheaths
  • Steerable sheaths

Interventional Cardiology & Peripheral Intervention Products:

  • Introducer kits
  • Guiding extension catheters
  • Balloon catheters
  • Guiding catheters
  • Microcatheters
  • Guidewires
  • Hydrophilic angiographic catheters
  • Hydrophilic guidewires
  • Hemostasis introducers
  • Radial compression devices
  • Aspiration catheters
  • Inflation devices
  • Y connectors
  • Snare kits
  • Hemostasis valves
  • L guiding sheaths
  • Balloon occlusion microcatheters
  • Embolic protection devices
  • Transjugular liver access sets
  • Steerable guiding sheaths

OEM/ODM Services

APT Medical Inc. also provides comprehensive OEM/ODM solutions, including:

  • Project design and development
  • Customization services
  • Volume OEM production

Frequently Asked Questions

  • What is APT Medical's (SHA-688617) current market cap?
    As of 06/20/2025, APT Medical (including the parent company, if applicable) has an estimated market capitalization of $5.39 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • APT Medical global market capitalization ranking is approximately 3027 as of 06/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.